Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study

INTRODUCTION: Soluble urokinase-type plasminogen activator receptor (suPAR) strongly predicts outcomes and incident chronic kidney disease (CKD) in patients with cardiovascular disease (CVD). Whether the association between suPAR and CKD is a reflection of its overall association with chronic inflam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney Int Rep
Hauptverfasser: Hayek, Salim S., Ko, Yi-An, Awad, Mosaab, Ahmed, Hina, Gray, Brandon, Hosny, Kareem Mohammed, Aida, Hiroshi, Tracy, Melissa J., Wei, Changli, Sever, Sanja, Reiser, Jochen, Quyyumi, Arshed A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2017
Schlagworte:
Clinical Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5678674/
https://ncbi.nlm.nih.gov/pubmed/29142970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2017.02.001
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge